OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A randomised controlled trial of vaporised Δ9-tetrahydrocannabinol and cannabidiol alone and in combination in frequent and infrequent cannabis users: acute intoxication effects
Nadia Solowij, Samantha J. Broyd, Lisa‐Marie Greenwood, et al.
European Archives of Psychiatry and Clinical Neuroscience (2019) Vol. 269, Iss. 1, pp. 17-35
Open Access | Times Cited: 161
Nadia Solowij, Samantha J. Broyd, Lisa‐Marie Greenwood, et al.
European Archives of Psychiatry and Clinical Neuroscience (2019) Vol. 269, Iss. 1, pp. 17-35
Open Access | Times Cited: 161
Showing 1-25 of 161 citing articles:
Review of the Endocannabinoid System
Hui‐Chen Lu, Ken Mackie
Biological Psychiatry Cognitive Neuroscience and Neuroimaging (2020) Vol. 6, Iss. 6, pp. 607-615
Open Access | Times Cited: 368
Hui‐Chen Lu, Ken Mackie
Biological Psychiatry Cognitive Neuroscience and Neuroimaging (2020) Vol. 6, Iss. 6, pp. 607-615
Open Access | Times Cited: 368
Changes in delta‐9‐tetrahydrocannabinol (THC) and cannabidiol (CBD) concentrations in cannabis over time: systematic review and meta‐analysis
Tom P. Freeman, Sam Craft, Jack Wilson, et al.
Addiction (2020) Vol. 116, Iss. 5, pp. 1000-1010
Open Access | Times Cited: 254
Tom P. Freeman, Sam Craft, Jack Wilson, et al.
Addiction (2020) Vol. 116, Iss. 5, pp. 1000-1010
Open Access | Times Cited: 254
Cannabidiol: pharmacology and therapeutic targets
Stevie C. Britch, Shanna Babalonis, Sharon Walsh
Psychopharmacology (2020) Vol. 238, Iss. 1, pp. 9-28
Open Access | Times Cited: 221
Stevie C. Britch, Shanna Babalonis, Sharon Walsh
Psychopharmacology (2020) Vol. 238, Iss. 1, pp. 9-28
Open Access | Times Cited: 221
How does cannabidiol (CBD) influence the acute effects of delta-9-tetrahydrocannabinol (THC) in humans? A systematic review
Abigail M. Freeman, Kat Petrilli, Rachel Lees, et al.
Neuroscience & Biobehavioral Reviews (2019) Vol. 107, pp. 696-712
Open Access | Times Cited: 181
Abigail M. Freeman, Kat Petrilli, Rachel Lees, et al.
Neuroscience & Biobehavioral Reviews (2019) Vol. 107, pp. 696-712
Open Access | Times Cited: 181
‘Standard THC units’: a proposal to standardize dose across all cannabis products and methods of administration
Tom P. Freeman, Valentina Lorenzetti
Addiction (2019) Vol. 115, Iss. 7, pp. 1207-1216
Open Access | Times Cited: 173
Tom P. Freeman, Valentina Lorenzetti
Addiction (2019) Vol. 115, Iss. 7, pp. 1207-1216
Open Access | Times Cited: 173
Great Expectations: recommendations for improving the methodological rigor of psychedelic clinical trials
Jacob S. Aday, Boris D. Heifets, Steven D. Pratscher, et al.
Psychopharmacology (2022) Vol. 239, Iss. 6, pp. 1989-2010
Open Access | Times Cited: 148
Jacob S. Aday, Boris D. Heifets, Steven D. Pratscher, et al.
Psychopharmacology (2022) Vol. 239, Iss. 6, pp. 1989-2010
Open Access | Times Cited: 148
Lower-Risk Cannabis Use Guidelines (LRCUG) for reducing health harms from non-medical cannabis use: A comprehensive evidence and recommendations update
Benedikt Fischer, Tessa Robinson, Chris Bullen, et al.
International Journal of Drug Policy (2021) Vol. 99, pp. 103381-103381
Open Access | Times Cited: 135
Benedikt Fischer, Tessa Robinson, Chris Bullen, et al.
International Journal of Drug Policy (2021) Vol. 99, pp. 103381-103381
Open Access | Times Cited: 135
Assessment of Orally Administered Δ9-Tetrahydrocannabinol When Coadministered With Cannabidiol on Δ9-Tetrahydrocannabinol Pharmacokinetics and Pharmacodynamics in Healthy Adults: A Randomized Clinical Trial
C. Austin Zamarripa, Tory R. Spindle, Renuka Surujunarain, et al.
JAMA Network Open (2023) Vol. 6, Iss. 2, pp. e2254752-e2254752
Open Access | Times Cited: 47
C. Austin Zamarripa, Tory R. Spindle, Renuka Surujunarain, et al.
JAMA Network Open (2023) Vol. 6, Iss. 2, pp. e2254752-e2254752
Open Access | Times Cited: 47
Cannabidiol (CBD) use in psychiatric disorders: A systematic review
Stefania Bonaccorso, A Ricciardi, Caroline Zangani, et al.
NeuroToxicology (2019) Vol. 74, pp. 282-298
Open Access | Times Cited: 142
Stefania Bonaccorso, A Ricciardi, Caroline Zangani, et al.
NeuroToxicology (2019) Vol. 74, pp. 282-298
Open Access | Times Cited: 142
The Effects of Cannabidiol, a Non-Intoxicating Compound of Cannabis, on the Cardiovascular System in Health and Disease
Aleksandra Kicman, Marek Toczek
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 18, pp. 6740-6740
Open Access | Times Cited: 105
Aleksandra Kicman, Marek Toczek
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 18, pp. 6740-6740
Open Access | Times Cited: 105
Pharmacodynamic effects of vaporized and oral cannabidiol (CBD) and vaporized CBD-dominant cannabis in infrequent cannabis users
Tory R. Spindle, Edward J. Cone, Elia Goffi, et al.
Drug and Alcohol Dependence (2020) Vol. 211, pp. 107937-107937
Open Access | Times Cited: 98
Tory R. Spindle, Edward J. Cone, Elia Goffi, et al.
Drug and Alcohol Dependence (2020) Vol. 211, pp. 107937-107937
Open Access | Times Cited: 98
Cannabis, a cause for anxiety? A critical appraisal of the anxiogenic and anxiolytic properties
Lara Sharpe, Justin Sinclair, Andrew Kramer, et al.
Journal of Translational Medicine (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 91
Lara Sharpe, Justin Sinclair, Andrew Kramer, et al.
Journal of Translational Medicine (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 91
Cannabidiol treatment in hand osteoarthritis and psoriatic arthritis: a randomized, double-blind, placebo-controlled trial
Jonathan Vela, Lene Dreyer, Kristian Kjær Petersen, et al.
Pain (2021) Vol. 163, Iss. 6, pp. 1206-1214
Open Access | Times Cited: 79
Jonathan Vela, Lene Dreyer, Kristian Kjær Petersen, et al.
Pain (2021) Vol. 163, Iss. 6, pp. 1206-1214
Open Access | Times Cited: 79
Does cannabidiol make cannabis safer? A randomised, double-blind, cross-over trial of cannabis with four different CBD:THC ratios
Amir Englund, Dominic Oliver, Edward Chesney, et al.
Neuropsychopharmacology (2022) Vol. 48, Iss. 6, pp. 869-876
Open Access | Times Cited: 63
Amir Englund, Dominic Oliver, Edward Chesney, et al.
Neuropsychopharmacology (2022) Vol. 48, Iss. 6, pp. 869-876
Open Access | Times Cited: 63
Role of Cannabidiol in the Therapeutic Intervention for Substance Use Disorders
Francisco Navarrete, María S. García‐Gutiérrez, Ani Gasparyan, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 59
Francisco Navarrete, María S. García‐Gutiérrez, Ani Gasparyan, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 59
The phytochemical diversity of commercial Cannabis in the United States
Christiana J. Smith, Daniela Vergara, Brian Keegan, et al.
PLoS ONE (2022) Vol. 17, Iss. 5, pp. e0267498-e0267498
Open Access | Times Cited: 50
Christiana J. Smith, Daniela Vergara, Brian Keegan, et al.
PLoS ONE (2022) Vol. 17, Iss. 5, pp. e0267498-e0267498
Open Access | Times Cited: 50
Review: Cannabinoids as Medicinals
Jag Khalsa, Gregory Bunt, Kenneth Blum, et al.
Current Addiction Reports (2022) Vol. 9, Iss. 4, pp. 630-646
Open Access | Times Cited: 42
Jag Khalsa, Gregory Bunt, Kenneth Blum, et al.
Current Addiction Reports (2022) Vol. 9, Iss. 4, pp. 630-646
Open Access | Times Cited: 42
THC and CBD: Villain versus Hero? Insights into Adolescent Exposure
Nicholas Pintori, Francesca Caria, Maria Antonietta De Luca, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5251-5251
Open Access | Times Cited: 28
Nicholas Pintori, Francesca Caria, Maria Antonietta De Luca, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5251-5251
Open Access | Times Cited: 28
Acute Cannabinoids Produce Robust Anxiety-Like and Locomotor Effects in Mice, but Long-Term Consequences Are Age- and Sex-Dependent
Chelsea R. Kasten, Yanping Zhang, Stephen L. Boehm
Frontiers in Behavioral Neuroscience (2019) Vol. 13
Open Access | Times Cited: 72
Chelsea R. Kasten, Yanping Zhang, Stephen L. Boehm
Frontiers in Behavioral Neuroscience (2019) Vol. 13
Open Access | Times Cited: 72
Predicting the Potential for Cannabinoids to Precipitate Pharmacokinetic Drug Interactions via Reversible Inhibition or Inactivation of Major Cytochromes P450
Sumit Bansal, Neha Maharao, Mary F. Paine, et al.
Drug Metabolism and Disposition (2020) Vol. 48, Iss. 10, pp. 1008-1017
Open Access | Times Cited: 67
Sumit Bansal, Neha Maharao, Mary F. Paine, et al.
Drug Metabolism and Disposition (2020) Vol. 48, Iss. 10, pp. 1008-1017
Open Access | Times Cited: 67
Use of Cannabidiol for the Treatment of Anxiety: A Short Synthesis of Pre-Clinical and Clinical Evidence
Madison Wright, Patricia Di Ciano, Bruna Brands
Cannabis and Cannabinoid Research (2020) Vol. 5, Iss. 3, pp. 191-196
Open Access | Times Cited: 61
Madison Wright, Patricia Di Ciano, Bruna Brands
Cannabis and Cannabinoid Research (2020) Vol. 5, Iss. 3, pp. 191-196
Open Access | Times Cited: 61
Effect of Inhaled Cannabis for Pain in Adults With Sickle Cell Disease
Donald I. Abrams, Paul Couey, Niharika Dixit, et al.
JAMA Network Open (2020) Vol. 3, Iss. 7, pp. e2010874-e2010874
Open Access | Times Cited: 57
Donald I. Abrams, Paul Couey, Niharika Dixit, et al.
JAMA Network Open (2020) Vol. 3, Iss. 7, pp. e2010874-e2010874
Open Access | Times Cited: 57
Cannabis and Driving
Godfrey D. Pearlson, Michael C. Stevens, Deepak Cyril D’Souza
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 52
Godfrey D. Pearlson, Michael C. Stevens, Deepak Cyril D’Souza
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 52
The Impact of Cannabidiol on Human Brain Function: A Systematic Review
Albert Batalla, Julian Bos, Amber Postma, et al.
Frontiers in Pharmacology (2021) Vol. 11
Open Access | Times Cited: 49
Albert Batalla, Julian Bos, Amber Postma, et al.
Frontiers in Pharmacology (2021) Vol. 11
Open Access | Times Cited: 49
A scoping review of the use of cannabidiol in psychiatric disorders
Anna E. Kirkland, Matthew C. Fadus, Staci A. Gruber, et al.
Psychiatry Research (2021) Vol. 308, pp. 114347-114347
Open Access | Times Cited: 48
Anna E. Kirkland, Matthew C. Fadus, Staci A. Gruber, et al.
Psychiatry Research (2021) Vol. 308, pp. 114347-114347
Open Access | Times Cited: 48
